0 Комментарии
0 Поделились
1Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Courses
-
Войдите, чтобы отмечать, делиться и комментировать!
-
SGLT2 Inhibitors Market Size, Share & Forecast Analysis to 2030SGLT2 Inhibitors Market Size & Insights According to MarkNtel Advisors study The future of SGLT2 Inhibitors Market size was valued at around USD 18.41 billion in 2024 and is projected to reach USD 30.34 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.68% during the forecast period, i.e., 2025-30. What are the Key Driver in the SGLT2...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Can the Global Oral Antidiabetic Drugs Market Transform Diabetes Management Worldwide?Oral Antidiabetic Drugs Market Summary: According to the latest report published by Data Bridge Market Research, the Oral Antidiabetic Drugs Market CAGR Value This Oral Antidiabetic Drugs Market research report is prepared with detailed statistics and market research insights that results in sharp growth and thriving sustainability in the market for the businesses. This...0 Комментарии 0 Поделились 798 Просмотры 0 предпросмотр
-
Diabetes Treatments Market Size, Share, and Growth Forecast to 2030According to the latest report published by Data Bridge Market Research, the Diabetes Treatments Market Data Bridge Market Research analyses that the global diabetes treatments market which was USD 5,370.2 million in 2022, would rocket up to USD 8,920.9 million by 2030, and is expected to undergo a CAGR of 6.5 % during the forecast period. Type-1 segment dominates the type segment of...0 Комментарии 0 Поделились 282 Просмотры 0 предпросмотр
-
Global Diabetes Drugs Market Growing at 12.1% CAGR Through 2032According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...0 Комментарии 0 Поделились 141 Просмотры 0 предпросмотр